**Question:** Carrier stage seen in -

A. Penicillinase
B. Aminoglycosides
C. Tetracyclines
D. Fluoroquinolones

**Core Concept:** The carrier stage is a concept in pharmacokinetics, which describes the period during which the administered drug remains in a stable equilibrium between the blood and tissues. It occurs after the initial distribution phase and before the elimination phase. The carrier stage is essential in understanding the steady-state concentration of a drug, which is crucial for therapeutic efficacy and minimizing adverse effects.

**Why the Correct Answer is Right:**

**Option C: Tetracyclines** are a class of antibiotics that primarily target bacteria by inhibiting protein synthesis. They demonstrate a unique characteristic called "carrier absorption," where the drug is taken up into the enterocytes of the small intestine and then released into the bloodstream and tissues. This ensures a prolonged drug concentration in the body, which is essential for their antibacterial activity.

**Why Each Wrong Option is Incorrect:**

**Option A: Penicillinase** is an enzyme produced by certain bacteria that degrade penicillin antibiotics, rendering them ineffective. Penicillinase does not play a role in the carrier stage concept.

**Option B: Aminoglycosides:** Aminoglycosides are antibiotics with a broad-spectrum bactericidal activity. Unlike tetracyclines, their carrier stage does not involve carrier absorption, but rather, they are primarily distributed by passive diffusion and are poorly absorbed from the gastrointestinal tract.

**Option D: Fluoroquinolones:** Fluoroquinolones are a class of antibiotics with bactericidal activity against both Gram-positive and Gram-negative bacteria. Although they may exhibit a carrier stage, the explanation provided is less notable in comparison to tetracyclines. The carrier stage in fluoroquinolones is related to their penetration into tissues and cells, which is essential for their antibacterial activity.

**Clinical Pearl:** Understanding the carrier stage is crucial for selecting appropriate medications, adjusting dosing regimens, and predicting the steady-state concentrations of drugs. Adequate carrier stage ensures therapeutic drug levels, preventing suboptimal treatment outcomes and minimizing potential adverse effects.